Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVNC | AGMB | VSTM | ||
| Company | Revance Therapeutics | Agomab Therapeutics NV Adrs | Verastem Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.65 | 11.03 | 4.70 | ||
| High | 3.66 | 11.03 | 4.75 | ||
| Low | 3.65 | 10.40 | 4.30 | ||
| Latest | 3.65 | 10.55 | 4.32 | ||
| Change | +0.01 | -0.49 | -0.39 | ||
| % Change | +0.27% | -4.44% | -8.28% | ||
| Volume | 4,123,100 | 42,800 | 2,212,500 | ||
| 20-Day Average Volume | 2,900,350 | 103,200 | 2,282,270 | ||
| Previous Close | 3.64 | 11.04 | 4.71 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.53 | 11.31 | 5.51 | ||
| 20-Day Raw Stochastic | 89.36% | 8.83% | 0.85% | ||
| 20-Day Relative Strength | 52.71 | 43.52 | 34.39 | ||
| Weighted Alpha | -53.44 | N/A | -58.44 | ||
| Today's Opinion | 24% Sell | N/A | 100% Sell | ||
| Previous Opinion | 24% Sell | N/A | 100% Sell | ||
| Last Month's Opinion | 88% Sell | N/A | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.27% since 01/29/25 | -13.03% since 05/08/26 | -11.66% since 05/08/26 | ||
| Low | 3.62 on 01/30/25 | 10.40 on 05/15/26 | 4.30 on 05/15/26 | ||
| High | 3.66 on 02/05/25 | 12.44 on 05/12/26 | 5.29 on 05/11/26 | ||
| 1-Month | |||||
| %Chg | +18.12% since 01/03/25 | -1.03% since 04/15/26 | -31.75% since 04/15/26 | ||
| Low | 3.23 on 01/10/25 | 10.24 on 04/23/26 | 4.30 on 05/15/26 | ||
| High | 3.70 on 01/17/25 | 13.75 on 05/06/26 | 6.80 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | -37.50% since 11/05/24 | -31.23% since 02/13/26 | -25.77% since 02/13/26 | ||
| Low | 3.01 on 12/09/24 | 9.00 on 04/09/26 | 4.30 on 05/15/26 | ||
| High | 5.97 on 11/06/24 | 17.45 on 03/03/26 | 6.80 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | +19.28% since 08/05/24 | N/A since 02/06/26 | -42.82% since 11/14/25 | ||
| Low | 2.80 on 08/07/24 | 9.00 on 04/09/26 | 4.30 on 05/15/26 | ||
| High | 6.65 on 08/19/24 | 17.45 on 03/03/26 | 10.82 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 381,023 | 382,300 | 379,616 | ||
| Shares Outstanding, K | 104,390 | 36,237 | 87,874 | ||
| Annual Sales | 234,040,000 | 0 | 30,910,000 | ||
| Annual Net Income | -323,990,000 | -62,547,000 | -209,470,000 | ||
| Last Quarter Sales | 59,880,000 | 0 | 18,670,000 | ||
| Last Quarter Net Income | -38,120,000 | -17,401,000 | -36,590,000 | ||
| 60-Month Beta | 0.90 | N/A | 0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/07/24 | N/A | -0.46 on 05/07/26 | ||
| Earnings Date | 02/26/25 | 07/23/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||